These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15851782)

  • 1. "Safety and convenience of a 15-minute infusion of zoledronic acid": not so safe.
    Lugassy G
    Oncologist; 2005 May; 10(5):309-10; author reply 311-2. PubMed ID: 15851782
    [No Abstract]   [Full Text] [Related]  

  • 2. The issue of renal safety of zoledronic acid from a nephrologist's point of view.
    Balla J
    Oncologist; 2005 May; 10(5):306-8; author reply 311-2. PubMed ID: 15851781
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Berenson J, Hirschberg R. Safety and convenience of a 15-minute infusion of zoledronic acid.
    Diel IJ; Bergner R
    Oncologist; 2005 Jan; 10(1):82-3; author reply 84-7. PubMed ID: 15632256
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and convenience of a 15-minute infusion of zoledronic acid.
    Berenson J; Hirschberg R
    Oncologist; 2004; 9(3):319-29. PubMed ID: 15169987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid in myeloma: MRC Myeloma IX.
    Rajkumar SV
    Lancet; 2010 Dec; 376(9757):1965-6. PubMed ID: 21131042
    [No Abstract]   [Full Text] [Related]  

  • 6. Zoledronic acid. A bisphosphonate for hypercalcemia of malignancy and osteolytic metastases.
    Massaro AM
    Cancer Pract; 2002; 10(4):219-21. PubMed ID: 12100107
    [No Abstract]   [Full Text] [Related]  

  • 7. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
    Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer patients with bone complications prefer infusion of zoledronic acid.
    Oncology (Williston Park); 2003 Aug; 17(8):1070. PubMed ID: 12966674
    [No Abstract]   [Full Text] [Related]  

  • 9. Bisphosphonate infusions: patient preference, safety and clinic use.
    Chern B; Joseph D; Joshua D; Pittman K; Richardson G; Schou M; Lowe S; Copeman M; De Abreu Lourenco R; Lynch K
    Support Care Cancer; 2004 Jun; 12(6):463-6. PubMed ID: 15088136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of zoledronic acid in multiple myeloma.
    Tanimoto T; Matayoshi T; Yagasaki F; Takeuchi K; Kami M
    Lancet; 2011 Jun; 377(9784):2178. PubMed ID: 21704866
    [No Abstract]   [Full Text] [Related]  

  • 11. Regarding "recommendations for zoledronic acid treatment of patients with bone metastases".
    Parles K
    Oncologist; 2005 May; 10(5):304-5. PubMed ID: 15851780
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of zoledronic acid in multiple myeloma.
    Kyrgidis A; Tzellos TG
    Lancet; 2011 Jun; 377(9784):2177-8. PubMed ID: 21704864
    [No Abstract]   [Full Text] [Related]  

  • 13. Denosumab and bone metastases. No better than a bisphosphonate.
    Prescrire Int; 2012 Sep; 21(130):204-6. PubMed ID: 23016249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Bilateral Anterior Uveitis after a Single Intravenous Infusion of Zoledronic Acid in Metastatic Breast Cancer.
    Jun JH
    Korean J Ophthalmol; 2017 Aug; 31(4):368-369. PubMed ID: 28682020
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonates in prostate cancer: where are we and where should we go?
    Saad F
    J Natl Cancer Inst; 2003 Sep; 95(17):1262-3. PubMed ID: 12953073
    [No Abstract]   [Full Text] [Related]  

  • 16. Parenteral diphosphonates for treating malignant hypercalcemia.
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Cancer; 1981 Oct; 48(8):1922-5. PubMed ID: 6456809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of zoledronic acid rapid infusion in lung cancer patients with bone metastases: a single institution experience.
    Kotteas E; Alamara C; Kiagia M; Pantazopoulos K; Boufas A; Provata A; Charpidou A; Syrigos KN
    Anticancer Res; 2008; 28(1B):529-33. PubMed ID: 18383897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for zoledronic acid treatment of patients with bone metastases.
    Berenson JR
    Oncologist; 2005 Jan; 10(1):52-62. PubMed ID: 15632252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long interval zoledronic acid use in bone metastases.
    Das M
    Lancet Oncol; 2017 Feb; 18(2):e72. PubMed ID: 28089632
    [No Abstract]   [Full Text] [Related]  

  • 20. Iv dichloromethylene diphosphonate in cancer-associated hypercalcemia: a phase I-II evaluation.
    Cohen AI; Koeller J; Davis TE; Citrin DL
    Cancer Treat Rep; 1981; 65(7-8):651-3. PubMed ID: 6454484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.